Biotechnology company focusing on immune-driven medicine
Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (H.R. 4128/S. 2209) and the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S. 4348). Federal funding support for cellular immunity research and utilization; including Fiscal Year 2022 (H.R. 4502) and Fiscal Year 2023 Labor, Health and Human Services, and Education, and Related Agencies appropriations issues (S. 4659; H.R. 8295) and Fiscal Year 2023 Department of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations issues (S. 4661; H.R. 8239; H.R. 8294). Issues related to the Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021 (S. 1873 & H.R. 1946).
HCR - Health Issues BUD - Budget/Appropriations MMM - Medicare/Medicaid
136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ARNOLD & PORTER KAYE SCHOLER LLP
601 Massachusetts Ave. NW, Washington, DC, 20001, US
EUGENIA PIERSON KRISTINE BLACKWOOD BOBBY MCMILLIN PARI MODY CASEY BROUHARD NATALIE TIETJEN PETER DUYSHART EUGENIA PIERSON KRISTINE BLACKWOOD BOBBY MCMILLIN PARI MODY CASEY BROUHARD NATALIE TIETJEN PETER DUYSHART EUGENIA PIERSON KRISTINE BLACKWOOD BOBBY MCMILLIN PARI MODY CASEY BROUHARD NATALIE TIETJEN PETER DUYSHART